Patient Medications - Page 56

Patient Medications is the place for Registered Nurses to discuss patient medication administration, interactions, and dosing. General info about meds and hospital policy can be discussed.

 
  1.  
  2. VickyRN

    FDA Proposes Labeling Changes to Over-the-Counter Pain Relievers

    Last reply by VickyRN, MSN, DNP, RN
    • 3 replies
  3. VickyRN

    Learning the essentials of epidural anesthesia

    Last reply by VickyRN, MSN, DNP, RN
    • 0 replies
  4. VickyRN

    New Drugs and Indications

    Last reply by VickyRN, MSN, DNP, RN
    • 1 reply
  5. VickyRN

    New Drugs

    Last reply by VickyRN, MSN, DNP, RN
    • 0 replies
  6. Brian

    FDA Patient Safety videos for Healthcare professionals

    Last reply by Brian, ASN, RN
    • 0 replies
  7. bargainhound

    FDA update on Vail Beds

    Last reply by bargainhound, RN
    • 0 replies
  8. Brian

    FDA MedWatch: Reminyl (galantamine) precautions due to deaths re ported in clinical t

    Last reply by Nurse Ratched, RN
    • 1 reply
  9. hhrhrn41

    Type of Syringe for Heparin Injections?

    Nursing Q/A
    Last reply by unknown99, BSN, RN
    • 10 replies
  10. Brian

    U.S. Marshals seized lots of GlaxoSmithKline's Pax il CR (paroxetine hydrochloride)

    Last reply by Brian, ASN, RN
    • 0 replies
  11. Brian

    FDA MedWatch: Phenergan (promethazine) contraindicated in children < 2 y.o due to fa

    Last reply by Brian, ASN, RN
    • 0 replies
  12. Brian

    FDA MedWatch: Consumer Alert to not use unapproved Home-Use Diagn ostic Kits Marketed

    Last reply by Brian, ASN, RN
    • 0 replies
  13. Brian

    FDA MedWatch: ZyPREXA (olanzapine) and ZYRTEC (cetirizine HCI) medication errors due

    Last reply by Brian, ASN, RN
    • 0 replies
  14. Brian

    FDA MedWatch - Class 1 recall of Becton Dickinson ProbeTec ET Urine Processsing Kit

    Last reply by Ms.Hobbes
    • 1 reply
  15. Brian

    FDA MedWatch-Viramune [nevirapine] Public Health Advisory issued with indications and

    Last reply by Brian, ASN, RN
    • 0 replies
  16. Brian

    FDA MedWatch - Methylin CT [Methylphenidate HCl Chewable Tablets] recall due to exces

    Last reply by Brian, ASN, RN
    • 0 replies
  17. Brian

    FDA MedWatch - Aranesp (darbepoetin alfa) - Warnings revised to include reports of i

    Last reply by wmarat, BSN, RN
    • 1 reply
  18. Brian

    FDA MedWatch - November 2004 Safety Labeling Changes Posted

    Last reply by Brian, ASN, RN
    • 0 replies
  19. Brian

    FDA MedWatch - Cordarone (amiodarone HCl) and new Medication Guide

    Last reply by Brian, ASN, RN
    • 0 replies
  20. Brian

    Public Health Advisory: FDA Recommendations Concern ing the Use of NSAIDs

    Last reply by Jedi
    • 1 reply
  21. Brian

    Strattera (atomoxetine) warning about potential for severe liver injury

    Last reply by apri0608
    • 3 replies
  22. Brian

    FDA MedWatch - Remicade (infliximab) and severe hepatic reactions reported in postmar

    Last reply by sharann, BSN, RN
    • 1 reply
  23. Brian

    Naproxen - FDA Statement on halting of NIH clinical trial

    Last reply by Brian, ASN, RN
    • 0 replies
  24. Brian

    FDA Statement on risk of cardiovascular events in patients receiving Celebrex

    Last reply by Brian, ASN, RN
    • 0 replies
  25. Brian

    FDA MedWatch - October 2004 Safety Labeling Changes Posted

    Last reply by NRSKarenRN, BSN, RN
    • 2 replies
  26. Brian

    FDA MedWatch - Recall of CARDIAC Reader System due to falsely dec reased or false neg

    Last reply by Brian, ASN, RN
    • 0 replies